Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Sitagliptin in Individuals With Genetically Decreased DPP4
NCT04323189Phase 4Active, not recruiting
- Sponsor
- University of Pennsylvania
- Start
- Aug 2020
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by University of Pennsylvania. Started Aug 2020; status: active, not recruiting.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04323189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04323189.